Director/PDMR Shareholding

RNS Number : 5371X

GlaxoSmithKline PLC

06 May 2016

 

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

In accordance with DTR 3.1.4R (1) (a) I give details of changes in the interests of Mr Simon Dingemans, an Executive Director, in the ordinary shares of GlaxoSmithKline plc (the "Company") following the exercise of nil cost options over 19,008 ordinary shares on 6 May 2016, granted on 28 February 2013, which vested on 28 February 2016 under the GlaxoSmithKline Deferred Annual Bonus Plan. The Company delivered the net of tax value in shares being 9,894. The fair market value of an ordinary share at the point of exercise on 6 May 2016 was £14.50.

The Company and Mr Dingemans were advised of these transactions on 6 May 2016.

V A Whyte

Company Secretary

6 May 2016

 

END

 

 

DSHLQLFBQEFXBBB